Waterloo Brewing Ltd. (TSX:WBR) and Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) Being Impacted By Recent News, A Look into the Numbers

The Piotroski F-Score of Waterloo Brewing Ltd. (TSX:WBR) is 7.  The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength.  The score helps determine if a company’s stock is valuable or not.  A score of nine indicates a high value stock, while a score of one indicates a low value stock.  The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings.  It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue.  The score is also determined by change in gross margin and change in asset turnover.

Individual investors may be going to great lengths to make their hard earned money work for them in the stock market. The stock market can be a scary place for beginners with little to no experience. Studying the ins and outs of the markets can help provide a solid base for the new investor to work with. Many people will jump into the game thinking they are going to easily make large profits in the market. Although this is a possibility, many investors will learn the hard way that sustaining profits over the long-term can be a tough endeavor. Studying all the different company information can take up a lot of time and energy. Some people just don’t have the time they would like to put into stock market study. 

SMA 50/200

Ever wonder how investors predict positive share price momentum? The Cross SMA 50/200, also known as the “Golden Cross” is the fifty day moving average divided by the two hundred day moving average. The SMA 50/200 for Waterloo Brewing Ltd. (TSX:WBR) is currently 0.93631. If the Golden Cross is greater than 1, then the 50 day moving average is above the 200 day moving average – indicating a positive share price momentum. If the Golden Cross is less than 1, then the 50 day moving average is below the 200 day moving average, indicating that the price might drop.

The price to book ratio or market to book ratio for Waterloo Brewing Ltd. (TSX:WBR) currently stands at 3.050959.  The ratio is calculated by dividing the stock price per share by the book value per share.  This ratio is used to determine how the market values the equity.  A ratio of under 1 typically indicates that the shares are undervalued.  A ratio over 1 indicates that the market is willing to pay more for the shares.  There are often many underlying factors that come into play with the Price to Book ratio so all additional metrics should be considered as well. 

The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements.  The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth.  The C-Score of Waterloo Brewing Ltd. (TSX:WBR) is 2.00000.  The score ranges on a scale of -1 to 6.  If the score is -1, then there is not enough information to determine the C-Score.  If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.

Turning to Free Cash Flow Growth (FCF Growth), this is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of Waterloo Brewing Ltd. (TSX:WBR) is 1.768731.  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  

Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of Waterloo Brewing Ltd. (TSX:WBR) is 41.388100.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  

The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of Waterloo Brewing Ltd. (TSX:WBR) is 43.503500.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 37.476200.

MF Rank

The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price. The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital. The MF Rank of Waterloo Brewing Ltd. (TSX:WBR) is 8144. A company with a low rank is considered a good company to invest in. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.

The Q.i. Value of Waterloo Brewing Ltd. (TSX:WBR) is 35.00000.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.

Value Composite
The Value Composite One (VC1) is a method that investors use to determine a company’s value.  The VC1 of Waterloo Brewing Ltd. (TSX:WBR) is 49.  A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company.  The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings.  Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.  The Value Composite Two of Waterloo Brewing Ltd. (TSX:WBR) is 42.

ERP5 Rank

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Waterloo Brewing Ltd. (TSX:WBR) is 8982. The lower the ERP5 rank, the more undervalued a company is thought to be.

Active investors are constantly weighing risk and return when trading in the stock market. Every investor has to evaluate their risk appetite at some point. The amount of risk an investor is willing to take on can have a large impact on expected future returns. Some people may be much more comfortable with riskier investments than others. This can greatly vary from one person to the next. Once the individual investor is comfortable with the amount of money on the table, they should be able to spend their energies focused on finding a winning strategy. Finding a winning strategy may involve many different aspects of stock research. Following a plan may help investors plow through downturns in the markets, and being able to change the plan when things aren’t working can also be a help to longer-term portfolio health.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

The Piotroski F-Score of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 1.  The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength.  The score helps determine if a company’s stock is valuable or not.

 A score of nine indicates a high value stock, while a score of one indicates a low value stock.  The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings.  It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue.  The score is also determined by change in gross margin and change in asset turnover.

Many investors get into the stock market with unrealistic expectations. For whatever reason, they may have the mindset that snatching profits is easy. Thinking that profits can be doubled or tripled right away may lead the investor down the road of no return. Although the lucky few might hit some big winners right off the bat, these chances are quite low. Stocks tend to be volatile in the short-term. Unless investors have a game plan ready to capitalize on short-term movements, they may want to take a wider, longer-term approach. Trying to figure out which way the market will turn from one day to the next can be a highly frustrating procedure. Having the patience to thoroughly examine every trade can immensely boost the investor’s chances of surviving and thriving into the future.

Current Ratio

The Current Ratio of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 0.00. The Current Ratio is used by investors to determine whether a company can pay short term and long term debts. The current ratio looks at all the liquid and non-liquid assets compared to the company’s total current liabilities. A high current ratio indicates that the company might have trouble managing their working capital. A low current ratio (when the current liabilities are higher than the current assets) indicates that the company may have trouble paying their short term obligations.

The Return on Invested Capital (aka ROIC) for Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is -6.798746.  The Return on Invested Capital is a ratio that determines whether a company is profitable or not.  It tells investors how well a company is turning their capital into profits.  The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital.  The employed capital is calculated by subrating current liabilities from total assets.  Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a company’s ROIC over the course of five years.  The ROIC Quality of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is .  This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC.  The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets).  The ROIC 5 year average of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is .

The Gross Margin Score is calculated by looking at the Gross Margin and the overall stability of the company over the course of 8 years. The score is a number between one and one hundred (1 being best and 100 being the worst). The Gross Margin Score of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 50.00000. The more stable the company, the lower the score. If a company is less stable over the course of time, they will have a higher score.

MF Rank

The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price. The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital. The MF Rank of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 19487. A company with a low rank is considered a good company to invest in. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.

The Q.i. Value of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 86.00000.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.

Turning to Free Cash Flow Growth (FCF Growth), this is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is .  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  

Value Composite
The Value Composite One (VC1) is a method that investors use to determine a company’s value.  The VC1 of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 78.  A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company.  

The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings.  Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.  The Value Composite Two of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 75.

Volatility
Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 0.000000.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  

The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 62.644700.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 57.684700.

ERP5 Rank

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Entasis Therapeutics Holdings Inc. (NasdaqGM:ETTX) is 18642. The lower the ERP5 rank, the more undervalued a company is thought to be.

On a typical market day there is no shortage of stock news. Investors are often tasked with trying to decipher which news is worth paying attention to and which isn’t. Not only is there plenty of swirling news, there are usually plenty of opinions that follow. Closely following market sentiment can be useful for some, but it may impede others when decisions need to be made. When it comes to dedicated stock research, taking shortcuts may result in disappointing portfolio performance. Investors have to be careful not to be tempted by the hot stocks of the day. Of course, maybe some of those stocks would fit well in the portfolio, but doing individual stock study can help confirm the addition.